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Lv4, an activity that restricts nuclear entry of
SIVMAC/SIVSM in human blood cells
Massimo Pizzato1,2, Martha Neagu1, Thomas Pertel1, Claudia Firrito1, Serena Ziglio2, Madeleine Zufferey1,
Lionel Berthoux3, Jeremy Luban1,4*
From Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts
Cambridge, UK. 16-18 September 2013
SIVSM is a lentivirus endemic to the West African sooty
mangabey (Cercocebus atys). HIV-2 and SIVMAC are
zoonoses that resulted from SIVSM transmission to
humans and Asian rhesus macaques (Macaca mulatto),
respectively. Human leukemia cell lines, human periph-
eral blood mononuclear cells and CD4+ T cells, were 4
to 50-fold less permissive for SIVMAC and SIVSM than
for HIV-1. In contrast, SIVMAC transduction of human
adherent cell lines was equivalent to that of HIV-1.
Consistent with adaptation to human cells, HIV-2 was
not restricted as potently as was SIVMAC. SIVMAC trans-
duction of human blood cells was rescued up to the
level of HIV-1 by As2O3, a compound that increases the
infectivity of viruses in the context of TRIM5-mediated
restriction. Nonetheless, efficient knockdown of TRIM5
or cyclophilin A, a cytoplasmic factor that sometimes
regulates TRIM5 restriction activity, did not rescue SIV-
MAC tranduction of these cells. Substitution of HIV-1
CA with the CA from SIVMAC rendered HIV-1 poorly
infectious for Jurkat T cells. The block occurred after
completion of reverse transcription and the formation of
2-LTR circles, but before establishment of the provirus.
Heterokaryons resulting from fusion of permissive with
restrictive cells exhibited the restrictive phenotype, indi-
cating that SIV transduction of human blood cells is
inefficient due to a dominant-acting restriction factor.
These results demonstrate that the nucleus of human
blood cells possesses a TRIM5-like restriction factor
specific for the SIVMAC/SIVSM capsid and that, by
extension, cross-species transmission of SIVSM to
human cells necessitated adaptation of HIV-2 to this
restriction factor.
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